[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Last Updated: Wednesday, 26 January, 2005, 09:04 GMT
Vioxx drug ban hits Merck profits
Vioxx
Vioxx had been linked with an increased risk of heart problems
Profits at US pharmaceutical giant Merck fell 21%, after the firm was forced to withdraw its Vioxx painkiller last year.

Sales of the drug were halted amid safety fears on 30 September, causing a dip in fourth-quarter profits to $1.1bn (0.59bn), from $1.4bn a year ago.

The firm also added $604m pre-tax to its reserves for Vioxx litigation.

Better-than-expected sales of other key drugs led sales to rise 2.2% to $5.75bn, it announced late on Tuesday.

The firm has not yet established reserves to cover the cost of settling lawsuits from people who claim they have been harmed by using Vioxx.

The drug has been linked with an increased risk of serious heart problems and the company was aware of 575 lawsuits from 1,400 plaintiffs by the end of last year.


SEE ALSO:
Painkiller risk to gut revealed
04 Jan 05 |  Health
US drug safety checks 'slack'
18 Nov 04 |  Business
Drug firms hit by safety scares
19 Nov 04 |  Business
Merck shares dive on Vioxx fears
02 Nov 04 |  Business


RELATED INTERNET LINKS:
The BBC is not responsible for the content of external internet sites


PRODUCTS AND SERVICES

News Front Page | Africa | Americas | Asia-Pacific | Europe | Middle East | South Asia
UK | Business | Entertainment | Science/Nature | Technology | Health
Have Your Say | In Pictures | Week at a Glance | Country Profiles | In Depth | Programmes
Americas Africa Europe Middle East South Asia Asia Pacific